FDA staff sees J&J psoriasis drug risks (Reuters)

[riky]

FDA staff sees J&J psoriasis drug risks
    (Reuters)

 


Reuters - An experimental psoriasis drug from
Johnson & Johnson was effective in clinical trials, but
long-term use may increase the risk of cancer, U.S. drug
reviewers said in documents released on Friday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080613/hl_nm/johnsonandjohnson_psoriasis_dc